ENTITY

Caliway Biopharmaceuticals (6919 TT)

48
Analysis
Health Care β€’ Taiwan
Caliway Biopharmaceuticals Co., Ltd. focuses on breakthrough medical aesthetics and inflammatory medicine discovery of small molecule therapeutics. The Company develops CBL-514 to treat subcutaneous fat. Caliway Biopharmaceuticals conducts businesses across worldwide.
more
bullishβ€’King Slide Works
β€’25 Aug 2025 19:35

Quiddity Leaderboard T50/​​​100 Sep25: Final Expectations; Tung Ho Steel Safe from TDIV Deletion

T100 and TDIV index member Tung Ho Steel Enterprise (2006 TT) is unlikely to be deleted from T100 or TDIV in September 2025.

Share
β€’17 Dec 2024 12:54

Quiddity TDIV/50/100 Dec 24 Results: 100% Hit Rate; 20x+ ADV for Many Names; US$2.3bn One-Way

The TDIV Inclusions/Exclusions will be equally-distributed over five trading days from 20th December 2024 to 26th December 2024. It is a good time...

Logo
1.2k Views
Share
β€’02 Dec 2024 16:01

Quiddity Leaderboard T50/​​​100 Dec 24:Β  TDIV Exp ADD/DEL In the Money; Strong Trade Performance

United Integrated Services (2404 TT) has outperformed Formosa Sumco (3532 TT) by 39% since 22nd October 2024. Now it might be time to unwind this...

Share
x